These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31603965)

  • 1. Lamotrigine-induced cutaneous pseudolymphoma.
    Reed KL; Quinn KB; Gust AJ
    Cutis; 2019 Aug; 104(2):E1-E3. PubMed ID: 31603965
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythematous-to-brownish plaques on the upper back: a quiz. Phenytoin-induced T-cell predominant pseudolymphoma (“pseudomycosis fungoides”) with T-cell clonality.
    Toberer F; Hartschuh W; Kutzner H; Flux K
    Acta Derm Venereol; 2015 Mar; 95(3):378-82. PubMed ID: 25111894
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous lymphoid hyperplasia and reactive lymphadenopathy induced by hepatitis B vaccination.
    Atalar H; Sarifakioglu E; Dener C; Yanik B; Koktener A; Bayrak R
    Eur J Dermatol; 2008; 18(2):188-9. PubMed ID: 18424381
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine.
    Cogrel O; Beylot-Barry M; Vergier B; Dubus P; Doutre MS; Merlio JP; Beylot C
    Br J Dermatol; 2001 Jun; 144(6):1235-8. PubMed ID: 11422049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced CD30+ T cell pseudolymphoma.
    Fukamachi S; Sugita K; Sawada Y; Bito T; Nakamura M; Tokura Y
    Eur J Dermatol; 2009; 19(3):292-4. PubMed ID: 19336342
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced pseudolymphoma secondary to lamotrigine.
    Pathak P; McLachlan RS
    Neurology; 1998 May; 50(5):1509-10. PubMed ID: 9596028
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous pseudolymphoma associated with bromocriptine therapy.
    Wiesli P; Joos L; Galeazzi RL; Dummer R
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):656-7. PubMed ID: 11106930
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
    Gardair Bouchy C; Kerdraon R; Kluger N; Armingaud P; Wakosa A; Estève E
    Ann Pathol; 2013 Aug; 33(4):273-7. PubMed ID: 23954123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia.
    Vaccaro M; Barbuzza O; Borgia F; Cannavò SP
    Dermatol Ther; 2015; 28(2):65-7. PubMed ID: 25627907
    [No Abstract]   [Full Text] [Related]  

  • 10. Cutaneous intralymphatic CD30
    Gralewski J; Post GR
    Blood; 2018 Oct; 132(17):1859. PubMed ID: 30361464
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphomatoid drug reaction secondary to methylphenidate hydrochloride.
    Welsh JP; Ko C; Hsu WT
    Cutis; 2008 Jan; 81(1):61-4. PubMed ID: 18306850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pustular dermatosis of the scalp due to topical minoxidil 5.
    El Anzi O; Hassam B
    Pan Afr Med J; 2018; 30():83. PubMed ID: 30344867
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbamazepine-induced pseudolymphoma with CD-30 positive cells.
    Nathan DL; Belsito DV
    J Am Acad Dermatol; 1998 May; 38(5 Pt 2):806-9. PubMed ID: 9591791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug induced pseudolymphoma secondary to ethosuximide.
    Masruha MR; Marques CM; Vilanova LC; de Seixas Alves MT; Peres MF; Rodrigues MG
    J Neurol Neurosurg Psychiatry; 2005 Nov; 76(11):1610. PubMed ID: 16227569
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare cutaneous side-effect of gefitinib masquerading as superficial dermatophytosis.
    Lin SS; Tsai TH; Yang HH
    Clin Exp Dermatol; 2009 Jun; 34(4):528-30. PubMed ID: 19196304
    [No Abstract]   [Full Text] [Related]  

  • 17. Dermatitis and alopecia in a patient treated with dupilumab: a new adverse effect?
    Salgüero-Fernández I; Gonzalez de Domingo MA; Suarez D; Roustan-Gullón G
    Clin Exp Dermatol; 2019 Apr; 44(3):e41-e43. PubMed ID: 30536947
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenytoin-like hypersensitivity associated with lamotrigine.
    Jones D; Chhiap V; Resor S; Appel G; Grossman ME
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1016-8. PubMed ID: 9204073
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome.
    Choi TS; Doh KS; Kim SH; Jang MS; Suh KS; Kim ST
    Br J Dermatol; 2003 Apr; 148(4):730-6. PubMed ID: 12752131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30-positive T-cell-rich pseudolymphoma induced by gold acupuncture.
    Kim KJ; Lee MW; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2002 May; 146(5):882-4. PubMed ID: 12000389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.